Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
2.510
-0.240 (-8.73%)
At close: Apr 1, 2025, 4:00 PM
2.728
+0.218 (8.68%)
After-hours: Apr 1, 2025, 4:02 PM EDT
Evoke Pharma Market Cap
Evoke Pharma has a market cap or net worth of $5.20 million as of April 1, 2025. Its market cap has decreased by -8.69% in one year.
Market Cap
5.20M
Enterprise Value
-2.84M
1-Year Change
-8.69%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since September 25, 2013, Evoke Pharma's market cap has decreased from $67.90M to $5.20M, a decrease of -92.34%. That is a compound annual growth rate of -19.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 4.10M | -37.88% |
| Dec 31, 2024 | 6.60M | 88.57% |
| Dec 29, 2023 | 3.50M | -61.11% |
| Dec 30, 2022 | 9.00M | -50.00% |
| Dec 31, 2021 | 18.00M | -73.57% |
| Dec 31, 2020 | 68.10M | 73.28% |
| Dec 31, 2019 | 39.30M | -9.03% |
| Dec 31, 2018 | 43.20M | 24.14% |
| Dec 29, 2017 | 34.80M | 39.76% |
| Dec 30, 2016 | 24.90M | 5.51% |
| Dec 31, 2015 | 23.60M | -34.63% |
| Dec 31, 2014 | 36.10M | -20.48% |
| Dec 31, 2013 | 45.40M | -33.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |